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Abstract
Background: The Social Engagement Framework for Addressing the Chronic-disease-challenge (SEFAC) project
intends to empower citizens at risk of or with type 2 diabetes (T2DM) and/or cardiovascular disease (CVD) to self-
manage their chronic conditions through the SEFAC intervention. The intervention combines the concepts of
mindfulness, social engagement and information and communication technology support, in order to reduce the
burden of citizens with chronic conditions and to increase the sustainability of the health system in four European
countries.
Methods: A prospective cohort study with a 6-month pre-post design will be conducted in four European countries:
Croatia, Italy, the Netherlands and the United Kingdom. A total of 360 community-dwelling citizens ≥50 years of age
will be recruited; 200 citizens at risk of T2DM and/or CVD in the next 10 years (50 participants in each country) and 160
citizens with T2DM and/or CVD (40 participants in each country). Effects of the intervention in terms of self-
management, healthy lifestyle behavior, social support, stress, depression, sleep and fatigue, adherence to
medications and health-related quality of life will be assessed. In addition, a preliminary cost-effectiveness
analysis will be performed from a societal and healthcare perspective.
Discussion: The SEFAC project will further elucidate whether the SEFAC intervention is feasible and (cost-)
effective among citizens at risk of and suffering from T2DM and/or CVD in different settings.
Trial registration: ISRCTN registry number is ISRCTN11248135. Date of registration is 30/08/2018 (retrospectively registered).
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Background
Persons with a chronic condition are responsible for the
management of their chronic condition everyday [1].
Successful self-management of chronic conditions could
help citizens handle their life with independence to some
extent despite their medical condition and to feel healthy
despite their limitations [2]. Moreover, within the con-
text of the overloaded healthcare and welfare systems,
the ability of citizens with a chronic condition to take
care of themselves for as long as possible has become in-
creasingly important [1, 2].
Several concepts have recently been explored as a
basis to define the most effective and efficient model to
deal with the chronic condition challenge [3]. One of
these concepts concerns mindfulness. A review of 15
studies suggested that mindfulness-based stress reduc-
tion interventions could help participants with chronic
conditions to better cope with symptoms and better
achieve overall well-being, quality of life and health out-
comes [4]. Some studies indicate that a mindfulness
intervention is an effective tool for diabetes as well as
chronic low back pain self-management [5, 6].
A second concept concerns social engagement. Social
engagement programmes provide practical support to
help citizens achieve aspirations and make them better
connected to their community. One example of a social
engagement programme is the Newquay Pathfinder
Programme [7]. Important conceptual elements of this
programme include shaping services around people and
communities, motivating people to achieve their aspira-
tions through a ‘guided conversation’ and the use of vol-
unteers [7, 8].
Information and communication technology (ICT) (for
instance, a telephone-based interactive system or an ap-
plication on smartphone) is the third concept which is
considered as an important enabler of self-management
partnership [1]. This means that people with chronic
conditions can self-manage their health using ICT and
health professionals are consulted to support them in
this role [1, 9, 10]. Previous studies indicate that ICT
support improves the self-management of citizens with
chronic conditions [11, 12].
Numerous studies have demonstrated the effectiveness
of self-management programmes [13–15]. However,
most studies have focused on a specific concept and/or a
specific chronic condition [16]. Furthermore, cross
country comparisons of the effectiveness of these pro-
grammes are recommended as well as cost-efficiency
data regarding these self-management programme [17].
The SEFAC project
The Social Engagement Framework for Addressing the
Chronic-disease-challenge (SEFAC) project was set up to
respond to the call of the Third EU Health Programme
(2014–2020; PJ-04-2016: Support to Member States and
stakeholders to address the chronic disease challenge;
http://sefacproject.eu). The aim of the SEFAC project is
to empower citizens ≥50 years of age at risk of or with
type 2 diabetes (T2DM) and/or cardiovascular disease
(CVD) to self-manage their chronic conditions through
the SEFAC intervention which combines the concepts of
mindfulness, social engagement as well as ICT support.
Furthermore, the project will evaluate (cost) effective-
ness, which will provide insight in costs of potential
policies contributing to the prevention of chronic condi-
tions. In this project, study sites in four European coun-
tries will implement the SEFAC intervention: Rijeka in
Croatia, Treviso in Italy, Rotterdam in the Netherlands
and Camborne in the United Kingdom.
Objectives
The main objective of this paper is to evaluate the
SEFAC intervention in terms of benefits for the target
population (citizens ≥50 years of age at risk of or with
T2DM and/or CVD). The following research questions
will be answered:
1. What are the effects of the SEFAC intervention for
participants in terms of self-management, healthy life-
style behavior, social support, stress, depression, sleep
and fatigue, adherence to medications and health-related
quality of life (HRQoL)?
2. What are the societal cost savings of the SEFAC
intervention in terms of reducing healthcare utilization
and productivity losses among the target population?
3. To what extent is the target population satisfied
with the SEFAC intervention as a whole and with its
three specific elements (mindfulness, social engagement
and ICT support)?
Study hypotheses
Our hypothesis is that the SEFAC intervention will im-
prove the self-management skills of participants, pro-
mote more favorable lifestyle behaviors, improve social
support, reduce participants’ stress, depression, sleeping
problems and fatigue and improve participants’ adher-
ence to medication and HRQoL at 6 month of follow-up
compared to baseline. In addition, we hypothesize that
society will benefit from the intervention through to a
reduced use of healthcare resources and greater product-
ivity. Finally, we hypothesize to reach a satisfaction score
of 7 or higher on a 1–10 scale for the SEFAC interven-
tion as a whole, with higher scores representing greater
satisfaction.
Methods/design
The SEFAC intervention
The SEFAC intervention was designed and developed by
partners of the SEFAC project and includes the concepts
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of mindfulness, social engagement as well as ICT sup-
port (Fig. 1), which are offered to participants in parallel.
Mindfulness training is offered in a series of 3 to 7
workshops, 2.5 h each, which will be held once a week
for 3 to 7 weeks. Every training will be led by trained
mindfulness professionals. The training includes three
‘obligatory’ workshops on training mind and body for
health and wellbeing, healthy habits and a healthy mind-
set as well as four voluntary workshops on healthy eat-
ing, healthy physical activity, healthy relationships and
healthy life with chronic conditions. The number of par-
ticipants per training will be no more than 30. Over the
workshops, participants will learn to foster greater
awareness of present moment experience to help them
better manage life’s ups and downs, support a healthy
lifestyle and enhance the quality of daily life.
In parallel to the mindfulness training, participants are
invited to enroll in the social engagement programme of
the SEFAC project which is based on the Newquay Path-
finder Programme [7]. The precise role of the volunteers
may differ depending on the geographical, cultural and
social context of the four study sites. At least, volunteers
help citizens identify ways to build self-confidence and
self-reliance through guided conversations [7]. In
addition, they may support the mindfulness training and
provide practical help in adopting major lifestyle changes
and in getting better connected to their community.
Finally, participants will be invited to download the
free SEFAC app on their mobile phone and use it as ICT
support for 6 months, starting from the first workshop.
The SEFAC app is a multi-modular tool that has been
developed for the android operating system. The app
aims to support change of lifestyle behaviors among
people with and without chronic conditions, according
to the stage of change the individual is in at a particular
point in time. Participants are encouraged to engage in
the practices, lessons, tips and reflections offered
through the app (see Additional file 1: Figure S1; Add-
itional file 2: Figure S2; Additional file 3: Figure S3; Add-
itional file 4: Figure S4; Additional file 5: Figure S5).
Study design, setting and procedures
A prospective cohort study with a 6-month pre-post de-
sign will be conducted [18]. Six-month follow-up data of
participants will be compared with the same participant’s
baseline data. The study protocol has been reviewed by
the Ethical Review Boards at the study sites in Rijeka,
Treviso, and Rotterdam; at the study site in Camborne
the decision tool of the NHS Health Research Authority
was applied in accordance with the applicable regula-
tions in the UK. See Declaration section. In all cases,
written informed consent is obtained before participants
enter the study.
In each study site, we will recruit community-dwelling
citizens over 50 years old using different strategies taking
the capacity, organizational and environmental charac-
teristics of the 4 study sites in consideration, as de-
scribed below.
Rijeka is a port city in the Republic of Croatia with a
population of 128,384 [19].Participants will be recruited
from public health events where free health checks are
provided, including measurement of blood pressure and
blood glucose, as well as through free community exer-
cise programmes. Interested citizens can talk about the
Fig. 1 The SEFAC intervention
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risk of developing T2DM and/or CVD with a health pro-
fessional. Eligible citizens are informed about the SEFAC
project and are invited to provide written informed con-
sent and to participate in the study.
Treviso is a city in the Veneto region in northeast Italy
with 85,200 inhabitants [20]. Participants will be re-
cruited from open events and through announcements
on health-related social network platforms. Interested
citizens can talk face-to-face with health professionals
about the risk of developing T2DM and/or CVD, and
can be suggested to visit their general practitioner (GP).
Eligible citizens are informed about the SEFAC project
and are invited to provide written informed consent and
to participate in the study.
Rotterdam is a port city in the Netherlands with a
population of 644,527 [21]. Participants will be recruited
from open community events and public announce-
ments. Citizens are informed about the SEFAC project
in-person and/or via the SEFAC website. Interested citi-
zens can express their interest to participate online, by
e-mail and in a conversation with a health professional,
face-to-face or by telephone. Eligible citizens are invited
by the research team to provide written informed con-
sent and to participate in the study.
Camborne is a town in South West England with a
population of 20,436 [22]. Participants will be recruited
by informing and inviting visitors of the Veor Surgery, a
general practitioner practice. Recruitment will also take
place through open events. Eligible participants will re-
ceive information about the SEFAC project and are in-
vited to provide written informed consent and to
participate.
Study population and eligibility to participate in the
study
We aim to include 360 participants in total (90 partici-
pants in each study site). The target population consists
of community-dwelling citizens ≥50 years of age, of
which 200 participants at risk of T2DM and/or CVD in
the next 10 years (50 participants in each study site) and
160 participants with T2DM and/or CVD (40 partici-
pants in each study site). Citizens are not eligible to par-
ticipate when they are diagnosed with mild or serious
cognitive impairment, terminally ill or scheduled to
enter secondary or tertiary care settings for a long period
of time, lack the basic knowledge of the local language
or are not able to make an informed decision regarding
participation in the study.
Data collection
Data will be collected from participants before the start
of the first workshop (baseline, T0) and at 6 months
(T1) with the use of a questionnaire. The instruments
used for the outcome measures are described in
measurements section. The instruments or items with-
out validated translations are translated by translators.
The study team discussed the translations and adapted
the translation when needed.
Measurements
Our objective is to evaluate the effects of the SEFAC inter-
vention on self-management, healthy lifestyle behavior, so-
cial support, stress, depression, sleep and fatigue, adherence
to medications and HRQoL. Self-management is measured
with General Self-efficacy Scale (GES) [23] as well as the
short 6-item version of the Chronic Disease Self-Efficacy in-
strument (CDSE-6) [24] which measure the confidence in
one’s ability to deal with health problems. The CDSE-6
covers domains that are common across many chronic con-
ditions, such as symptom control, role function, emotional
functioning and communicating with physicians.
With respect to healthy lifestyle behavior, we will as-
sess physical activity, healthy eating, sedentary behavior,
smoking and alcohol use. Physical activity is measured
with six items on physical exercise [24] and five items of
The Physical Exercise Self-Efficacy Scale (PESES) [25].
Healthy eating is measured with three items on the in-
take of fruits, vegetables and breakfast and five items of
The Nutrition Self-Efficacy Scale (NSES) [26]. Sedentary
behavior is measured with one item from the Inter-
national Physical Activity Questionnaire (IPAQ) [27],
current smoking is assessed with a single yes/no ques-
tion and the frequency of alcohol use is determined with
one item from the AUDIT-C [28].
Social support is measured with the 3-item Oslo
Social Support scale (OSS-3), regarding the primary
support group, interest and concern shown by others
and ease of obtaining practical help [29]. Stress is
measured with the 10-item Perceived Stress Scale
(PSS-10) [30]. Depression is measured with the
8-item Patient Health Questionnaire depression scale
(PHQ-8) [31]. Sleep and fatigue are measured with
visual analog scales, ranging from 0 (no sleeping
problem/fatigue) to 10 (severe sleeping problem/
fatigue).
Adherence to medication is measured with six items from
the Short Medication Adherence Questionnaire (SMAQ)
[32], a short tool based on questions posed directly to the
participant regarding his/her medication-taking habits.
HRQoL is measured with the 12-item Short-Form health
survey (SF-12) [33] and the EuroQol- 5 Dimensions- 5 level
(EQ-5D-5 L) instrument [34]. The SF-12 is a
patient-reported survey which includes both a physical di-
mension (physical functioning, role-physical, pain and gen-
eral health) and a mental dimension (vitality, social
functioning, role-emotional and mental health). SF-12 scores
can be summarized in the Physical Component Summary
(PCS) and the Mental Component Summary (MCS),
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ranging from 0 (worst) to 100 (best quality of life) [33]. The
EQ-5D-5 L is often used in the Quality-Adjusted Life Year
calculation to determine the cost-effectiveness of an inter-
vention. It has five dimensions: mobility, self-care, activity,
pain and anxiety. Each dimension has five levels, ranging
from no problems (level 1) to serious problems (level 5).
Hence, the EQ-5D-5 L has 3125 possible health states. Util-
ity values for these health states are available for the study
sites of each participating country [34]. As part of the
EQ-5D-5 L, participants are also asked to indicate their ex-
perienced current health state on a visual analog scale, 0 be-
ing the worst imaginable health and 100 being the best
imaginable health.
Additionally, we will evaluate healthcare utilization
and productivity losses. Healthcare utilization is mea-
sured with four questions from the Self-Management
Resource Center (SMRC) Health Care Utilization ques-
tionnaire regarding doctor appointments, the use of hos-
pital emergency rooms and hospital admissions [35, 36].
Productivity losses are measured with two domains from
the Productivity Costs Questionnaire (PCQ): lost prod-
uctivity at paid work due to absenteeism (6 items) and
lost productivity at unpaid work (3 items) [37].
Socio-demographic characteristics include age, gender,
country of birth, marital status, household composition,
education level, employment situation and health condi-
tions. There is an open box at the end of the question-
naire for any additional remarks.
The follow-up questionnaire at 6months (T1) will be
identical to the baseline questions except for the addition of
questions on the satisfaction of the target population with
the intervention. In the T1-questionnaire, we will add 6
items to rate the satisfaction with the whole SEFAC inter-
vention as well as specific concepts (mindfulness, social en-
gagement and ICT support) on a scale from 1 to 10.
Power considerations
The power considerations are conducted according to
the methods of a previous study [38]. We will include
net 113 participants at T0 in each study site (4 study
sites * 113 = 452 study participants). When the loss to
follow-up between T0 and T1 will be 20%, we will
have complete data of 360 participants at T1. Assum-
ing equal standard deviations (SD) at T0 and T1, an
alpha of 0.05 and power of 0.80, and taking into ac-
count the cluster design (4 participating study sites)
with an average cluster size of 90 participants (360/4)
and an intra-class correlation coefficient of 0.02, a
difference of 0.24 SD between T0 and T1 can be
established regarding the continuous outcome mea-
sures for this expected sample size and under these
conditions. For instance, regarding HRQoL as mea-
sured by the SF-12, a difference of 2.74 points can be
established between T0 and T1 for the PCS (SD =
11.4) and 2.86 points for the MCS (SD = 11.9) [39].
Statistical analysis
Descriptive statistics will describe characteristics of
participants in the total study population and in each
study site. In order to evaluate differences between
T0 and T1 measurements, multiple linear regression
analyses (for continuous outcome variables) and mul-
tiple logistic regression analyses (for dichotomous var-
iables) will be adopted in the total study population.
In addition, the analyses will be done for each study
site separately, and possibly other subgroups analyses
will be performed through formal interaction tests for
variables that will likely effect the intervention itself,
such as age, gender and education level.
A preliminary cost-effectiveness analysis will be per-
formed with the baseline measurement as control group
from a societal and healthcare perspective. Healthcare
costs for individual participants will be determined by
multiplying resource use with corresponding unit prices
for 2017, including doctor appointments, hospital emer-
gency rooms and hospital admissions. Productivity losses
for individual participants (lost productivity at paid work
due to absenteeism and lost productivity at unpaid
work) will follow from the PCQ. Utility values will be
obtained through the EQ-5D-5 L instrument.
Dissemination
An Advisory Board with experts from five countries
(China, Croatia, Finland, the Netherlands and Sweden)
has been set up. The Advisory Board will provide critical
suggestions and comments throughout the project. The
project team will disseminate the scientific project re-
sults through publications in scientific peer-reviewed
journals and conferences. We adopt the project website
(http://sefacproject.eu/) to further disseminate the key
findings of our project to all stakeholders. The European
Local Inclusion and Social Action Network (ELISAN)
will disseminate the project results through social media.
Discussion
This paper describes the design of a prospective cohort
study which aims to evaluate the effects of the SEFAC
intervention for citizens at risk of or with T2DM and/or
CVD on self-management, healthy lifestyle behaviors,
social support, stress, depression, sleep and fatigue, ad-
herence to medications and HRQoL as well as the
(cost-) effectiveness of the SEFAC intervention.
Strengths of the study are that, to our knowledge, this
study is the first to develop and implement an interven-
tion combining the concepts of mindfulness, social en-
gagement and ICT support in Europe. Our study may
provide evidences on the generalizability of the
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intervention in different European countries through
recruiting the target population in different settings.
Additionally, the SEFAC project will provide information
on cost-effectiveness of self-management programmes to
fulfill the gap of limited data in this area.
The study also has some limitations and challenges.
Firstly, recruiting citizens at risk of or with T2DM and/or
CVD may be a challenge. In order to increase the partici-
pation rates, open events aim at recruiting participants
will be held according to the capacity, organizational and
environmental characteristics of the 4 study sites. Sec-
ondly, it was not practicable to include a control group.
To ensure that a citizen would not feel excluded, we prefer
to offer the intervention to all citizens that meet our cri-
teria. Instead, we apply a 6-month pre-post design, using
the baseline measurement as the ‘control group’. Thirdly,
we will try to capture the most important confounding
factors in our questionnaire. However, it is still possible
that we miss relevant variables.
Chronic conditions are the main cause of morbidity
and mortality in Europe and due to their social impact
and economic implications, their prevention and man-
agement are important challenges in realizing the sus-
tainability of health systems in Europe. By combining
mindfulness training, social engagement and ICT
support, we expect the SEFAC intervention to be a feas-
ible and cost-effective programme to promote
self-management and self-care of citizens at risk of and
suffering from chronic conditions.
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